Weekly Digest – August 2025 Weekly Digest – August 2025 27 August 2025: HERTHENA-Breast04 Phase 3 trial of Patritumab deruxtecan initiated in patients with metastatic hormone receptor positive, HER2 negative breast cancer previously treated with endocrine therapy Daiichi Sankyo and […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id